Perspective > Medscape Ob/Gyn > Viewpoints COMMENTARY Ultrasound Markers Can Differentiate Benign, Malignant Masses Peter Kovacs, MD, PhD Disclosures May 04, 2016 0 ...

Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results. Journal of Clinical Oncology, 2017; JCO.2016.70.859 DOI: 10.1200/JCO.2016.70.8594 ...

Soft tissue sarcomas are a rare type of cancer that present as lumps in soft tissues, such as fat, muscle, fibrous tissues, and blood vessels. They account for 1% of all malignant tumors. One of ...

MRI has a sensitivity of 81% and a specificity of 98% for categorizing as malignant a lesion thought to be of indeterminate risk on ultrasound. 39,40 Computed tomography (CT) is the test of choice ...

Ultrasound is widely used to detect breast cancer early, but misdiagnosis of benign lesions as malignant tumors sometimes leads to unnecessary biopsies. To tackle this problem, scientists ...

In participants age 60 years and older, 50% of non-classic lesions developed into malignant tumors, they said. Ultrasound has not been proven specifically as a screening exam for ovarian cancer ...

A new cancer immunotherapy pairs ultrasound with specially engineered CAR T cells to destroy malignant tumors while sparing normal tissue. The new experimental therapy significantly slowed down ...

While lipomatous lesions account for 20% of all soft tissue tumors, hibernomas represent just 1% of all types of both benign and malignant lesions; fewer than 250 cases have been reported since 2016.

Because phyllodes tumors can return, you need careful follow-up after your surgery. Within 4 to 6 months of your surgery, see your doctor for a breast exam, mammogram, and ultrasound.

Malignant ovarian tumors are also classified based on where they originally started to grow. The most common type is called epithelial. It begins in the cells that line the ovary.

Cite this: Ultrasound Markers Can Differentiate Benign, Malignant Masses - Medscape - May 04, 2016.